Jump to content

Ethylflualprazolam

From Wikipedia, the free encyclopedia

Ethylflualprazolam
Identifiers
  • 8-Chloro-1-ethyl-6-(2-fluorophenyl)-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine
ChemSpider
Chemical and physical data
FormulaC18H14ClFN4
Molar mass340.79 g·mol−1
3D model (JSmol)
  • ClC1=CC=C2C(C(C3=CC=CC=C3F)=NCC4=NN=C(CC)N42)=C1
  • InChI=InChI=1S/C18H14ClFN4/c1-2-16-22-23-17-10-21-18(12-5-3-4-6-14(12)20)13-9-11(19)7-8-15(13)24(16)17/h3-9H,2,10H2,1H3
  • Key:SRZYAHVJONICNV-UHFFFAOYSA-N

Ethylflualprazolam is a benzodiazepine derivative[1] which has been sold as a designer drug. It is structurally similar to flualprazolam, only differing by the addition of an ethyl group instead of a methyl group on the triazole ring. Ethylflualprazolam was first detected in samples tested in Toronto, Canada in December 2025 in expected fentanyl samples.[2] It has since been detected by CanTEST in March 2026 in expected alprazolam 'Xanax' and 'RO39' pills.[3]

Effects

[edit]

Ethylflualprazolam is a relatively new research chemical, and very little is known about its pharmacological properties.

See also

[edit]

References

[edit]
  1. ↑ "Ethylflualprazolam". Cayman Chemical. Ann Arbor, Michigan.
  2. ↑ "126 samples checked: December 13 – 26, 2025". Toronto's Drug Checking Service. December 26, 2025.
  3. ↑ "Ethylflualprazolam found in expected 'alprazolam' pills - The Know". www.instagram.com. 2026-03-29. Retrieved 2026-04-04.